Chang Lingdan, Shi Hongjin, Ruan Zhifang, Fu Mengli, Li Rui, Yang Jiaxin, Zheng Yanghuang, Zeng Dan, He Xiaojie, Wang Xiaona, Zhang Jinsong, Hai Bing
Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
J Thorac Dis. 2024 Sep 30;16(9):5995-6011. doi: 10.21037/jtd-24-845. Epub 2024 Sep 6.
Endobronchial ultrasound (EBUS)-guided transbronchial biopsy with or without a guide sheath (EBUS-GS or EBUS-nGS) is commonly utilized for the diagnosis of peripheral pulmonary lesions (PPLs). The primary objective of this meta-analysis is to assess the diagnostic yield, surgical time, and safety of EBUS-GS and EBUS-nGS in patients presenting with PPLs, providing valuable insights for clinical decision-making.
We conducted a systematic search of four databases (PubMed, Embase, Web of Science, Cochrane Library) up to January 2024. Two researchers independently screened the retrieved articles, extracted the data, assessed the quality of the studies, and conducted statistical analysis through Review Manager 5.4 and STATA 14.0. Subgroup analysis was used to explore potential sources of heterogeneity. Publication bias was assessed through funnel plot tests. Sensitivity analyses were also performed to evaluate the robustness of the combined results.
The meta-analysis included data from nine studies comprising 2,898 patients. No publication bias was detected. There was no difference in the overall diagnostic rate of EBUS-GS and EBUS-nGS for PPLs [odds ratio (OR): 0.83, 95% confidence interval (CI): 0.64-1.08, Z-score (Z) =1.37, P=0.17]. Conversely, in cases utilizing a bronchoscope with an outer diameter of 3.0 mm (OR: 0.58, 95% CI: 0.40-0.84, Z=2.86, P=0.004), a 1.7-mm bronchoscope channel (OR: 0.70, 95% CI: 0.51-0.96, Z=2.21, P=0.03), or lesions ≤30 mm in size, or lesions situated in the lower lobe of the lung (OR: 0.59, 95% CI: 0.38-0.91, Z=2.36, P=0.02), the diagnostic rate was higher in the EBUS-nGS group. However, the EBUS-GS group demonstrated a tremendous advantage in terms of safety (OR: 0.64, 95% CI: 0.44-0.93, Z=2.33, P=0.02).
EBUS-GS and EBUS-nGS showed no significant difference in the overall diagnostic rate for PPLs. When using a bronchoscope with an outer diameter of 3.0 mm or a channel diameter of 1.7 mm, or when lesions are ≤30 mm or located in the lower lobe of the lung, EBUS-nGS demonstrated a higher diagnostic rate, and EBUS-nGS demonstrated a higher diagnostic rate. However, EBUS-GS exhibited more tremendous advantages in terms of safety.
支气管内超声(EBUS)引导下经支气管活检术,无论是否使用引导鞘(EBUS-GS或EBUS-nGS),都常用于诊断周围型肺部病变(PPL)。本荟萃分析的主要目的是评估EBUS-GS和EBUS-nGS在PPL患者中的诊断率、手术时间和安全性,为临床决策提供有价值的见解。
我们对截至2024年1月的四个数据库(PubMed、Embase、Web of Science、Cochrane图书馆)进行了系统检索。两名研究人员独立筛选检索到的文章,提取数据,评估研究质量,并通过Review Manager 5.4和STATA 14.0进行统计分析。采用亚组分析来探索异质性的潜在来源。通过漏斗图检验评估发表偏倚。还进行了敏感性分析以评估合并结果的稳健性。
荟萃分析纳入了9项研究的数据,共2898例患者。未检测到发表偏倚。EBUS-GS和EBUS-nGS对PPL的总体诊断率无差异[比值比(OR):0.83,95%置信区间(CI):0.64-1.08,Z值(Z)=1.37,P=0.17]。相反,在使用外径为3.0 mm的支气管镜(OR:0.58,95%CI:0.40-0.84,Z=2.86,P=0.004)、1.7 mm支气管镜通道(OR:0.70,95%CI:0.51-0.96,Z=2.21,P=0.03)、或病变大小≤30 mm、或位于肺下叶的病变(OR:0.59,95%CI:0.38-0.91,Z=2.36,P=0.02)的情况下,EBUS-nGS组的诊断率更高。然而,EBUS-GS组在安全性方面表现出巨大优势(OR:0.64,95%CI:0.44-0.93,Z=2.33,P=0.02)。
EBUS-GS和EBUS-nGS在PPL的总体诊断率上无显著差异。当使用外径为3.0 mm或通道直径为1.7 mm的支气管镜时,或当病变≤30 mm或位于肺下叶时,EBUS-nGS显示出更高的诊断率。然而,EBUS-GS在安全性方面表现出更大的优势。